{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:02:37Z","timestamp":1761962557918,"version":"build-2065373602"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T00:00:00Z","timestamp":1757721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T00:00:00Z","timestamp":1757721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s11845-025-04087-z","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T04:10:09Z","timestamp":1757736609000},"page":"1581-1587","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of SGLT-2 inhibitors on liver stiffness in patients with diabetes mellitus and heart failure: a Fibroscan study"],"prefix":"10.1007","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5713-004X","authenticated-orcid":false,"given":"Huseyin Ali","family":"Ozturk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7192-0280","authenticated-orcid":false,"given":"Hilmi Erdem","family":"Sumbul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,13]]},"reference":[{"key":"4087_CR1","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P et al (2019) Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 157:107843. https:\/\/doi.org\/10.1016\/j.diabres.2019.107843","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"4087_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tsch\u00f6pe C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62(4):263\u2013271","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"4087_CR3","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1056\/NEJMra063052","volume":"356","author":"S Neubauer","year":"2007","unstructured":"Neubauer S (2007) The failing heart\u2014an engine out of fuel. N Engl J Med 356(11):1140\u20131151","journal-title":"N Engl J Med"},{"issue":"1","key":"4087_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","volume":"61","author":"G Jia","year":"2018","unstructured":"Jia G, Whaley-Connell A, Sowers JR (2018) Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia 61(1):21\u201328","journal-title":"Diabetologia"},{"issue":"21","key":"4087_CR5","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE and others (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381(21):1995\u20132008","journal-title":"N Engl J Med"},{"key":"4087_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejim.2024.01.013","volume":"122","author":"M Zoncap\u00e8","year":"2024","unstructured":"Zoncap\u00e8 M, Liguori A, Tsochatzis EA (2024) Non-invasive testing and risk-stratification in patients with MASLD. Eur J Intern Med 122:11\u201319. https:\/\/doi.org\/10.1016\/j.ejim.2024.01.013","journal-title":"Eur J Intern Med"},{"key":"4087_CR7","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee; Introduction and Methodology: Standards of Care in Diabetes\u20142025.\u00a0Diabetes Care\u00a01 January 2025; 48 (Supplement_1): S1\u2013S5.\u00a0https:\/\/doi.org\/10.2337\/dc25-SINT","DOI":"10.2337\/dc25-SINT"},{"issue":"36","key":"4087_CR8","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M and others (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"4087_CR9","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B and others (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373:2117\u20132128","journal-title":"N Engl J Med"},{"key":"4087_CR10","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic V and others (2019) Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med 380:2295\u20132306","journal-title":"N Engl J Med"},{"key":"4087_CR11","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s11892-010-0122-6","volume":"10","author":"K Cusi","year":"2010","unstructured":"Cusi K (2010) The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes. Curr Diab Rep 10:306\u2013315","journal-title":"Curr Diab Rep"},{"key":"4087_CR12","first-page":"121","volume":"30","author":"A Mantovani","year":"2015","unstructured":"Mantovani A and others (2015) Nonalcoholic fatty liver disease and increased risk of incident type 2 diabetes. J Gastroenterol Hepatol 30:121\u2013127","journal-title":"J Gastroenterol Hepatol"},{"key":"4087_CR13","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1161\/CIRCULATIONAHA.118.034583","volume":"138","author":"M Packer","year":"2018","unstructured":"Packer M (2018) Targeting the epicardial adipose tissue in patients with heart failure with a preserved ejection fraction. Circulation 138:1733\u20131735","journal-title":"Circulation"},{"key":"4087_CR14","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV and others (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381:1995\u20132008","journal-title":"N Engl J Med"},{"key":"4087_CR15","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/CIRCULATIONAHA.120.045691","volume":"142","author":"M Packer","year":"2020","unstructured":"Packer M and others (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure. Circulation 142:1028\u20131039","journal-title":"Circulation"},{"key":"4087_CR16","first-page":"1798","volume":"37","author":"E Ferrannini","year":"2014","unstructured":"Ferrannini E and others (2014) Mechanisms of action of SGLT-2 inhibitors. Diabetes Care 37:1798\u20131807","journal-title":"Diabetes Care"},{"key":"4087_CR17","first-page":"2111","volume":"23","author":"S Kahl","year":"2021","unstructured":"Kahl S and others (2021) Mechanisms of sodium-glucose cotransporter-2 inhibitors in reducing hepatic steatosis. Diabetes Obes Metab 23:2111\u20132118","journal-title":"Diabetes Obes Metab"},{"key":"4087_CR18","first-page":"1512","volume":"158","author":"G Targher","year":"2020","unstructured":"Targher G and others (2020) Nonalcoholic fatty liver disease and increased risk of cardiovascular disease. Gastroenterology 158:1512\u20131523","journal-title":"Gastroenterology"},{"issue":"1","key":"4087_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM and others (2016) Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64(1):73\u201384","journal-title":"Hepatology"},{"issue":"8","key":"4087_CR20","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.2337\/dc18-0165","volume":"41","author":"MS Kuchay","year":"2018","unstructured":"Kuchay MS and others (2018) Effect of empagliflozin on liver fat in patients with type 2 diabetes: A randomized controlled trial (E-LIFT trial). Diabetes Care 41(8):1801\u20131808","journal-title":"Diabetes Care"},{"issue":"4","key":"4087_CR21","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cld.2009.07.009","volume":"13","author":"K Cusi","year":"2009","unstructured":"Cusi K (2009) Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis. Clin Liver Dis 13(4):545\u2013563","journal-title":"Clin Liver Dis"},{"issue":"13","key":"4087_CR22","first-page":"1298","volume":"27","author":"S Takase","year":"2021","unstructured":"Takase S and others (2021) Sodium-glucose cotransporter 2 inhibitors improve hepatic fibrosis in diabetes-associated non-alcoholic steatohepatitis model mice. World J Gastroenterol 27(13):1298\u20131314","journal-title":"World J Gastroenterol"},{"issue":"6","key":"4087_CR23","doi-asserted-by":"crossref","first-page":"101268","DOI":"10.1016\/j.diabet.2021.101268","volume":"47","author":"A Mantovani","year":"2021","unstructured":"Mantovani A and others (2021) SGLT-2 inhibitors and risk of incident liver disease: A meta-analysis of randomized controlled trials. Diabetes Metab 47(6):101268","journal-title":"Diabetes Metab"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-025-04087-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-025-04087-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-025-04087-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:01:15Z","timestamp":1761962475000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-025-04087-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,13]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["4087"],"URL":"https:\/\/doi.org\/10.1007\/s11845-025-04087-z","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"type":"print","value":"0021-1265"},{"type":"electronic","value":"1863-4362"}],"subject":[],"published":{"date-parts":[[2025,9,13]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Any part of this paper is not under consideration for publishing or published in anywhere else.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from all patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Adana City Training and Research Hospital Ethics Committee approved the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This manuscript was carried out in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights"}}]}}